Angioplasty Balloons Market : Overview and Growth Forecast to 2030
The global angioplasty balloons market is poised for steady growth, driven by rising cardiovascular disease incidence, expanding geriatric population, advancements in minimally invasive procedures, and increasing adoption of Drug-Eluting Balloons that offer enhanced efficacy in reducing restenosis rates.
angioplasty balloons market was valued
at US$
2.71 billion in 2022 and is projected to reach US$ 3.60
billion by 2030, growing at a CAGR of 3.6%
during the forecast period of 2022–2030. Angioplasty balloons play a crucial
role in percutaneous
coronary intervention (PCI) procedures by opening blocked or
narrowed blood vessels, restoring blood flow, and minimizing the need for
open-heart surgery. As demand for non-invasive cardiac treatment continues to
rise, the market is set to experience sustained growth.
Key Market Drivers
1. Rising Cardiovascular Diseases
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide.
According to the World Health Organization, CVDs account for over 17 million
deaths annually. The growing patient pool is directly contributing to the
increasing demand for angioplasty balloons, especially in regions with
high hypertension, diabetes, and smoking prevalence.
2. Technological Advancements
Innovation in balloon design, such as drug-eluting balloons (DEBs) and scoring
balloons, is enhancing procedural success rates. These
innovations reduce restenosis rates, lower post-procedure complications, and
improve long-term patient outcomes.
3. Minimally Invasive Nature of Angioplasty
The shift toward minimally invasive procedures is a significant
growth catalyst. Angioplasty offers shorter hospital stays, lower infection
risk, and faster recovery compared to open-heart surgery, making it the
preferred treatment for coronary artery disease.
Market Segmentation
The
angioplasty
balloons market is segmented based on product type,
application, end-user, and geography:
·
By Product Type:
Normal balloons, Drug-eluting balloons (DEBs), Scoring balloons, Cutting
balloons
·
By Application:
Coronary artery disease, Peripheral artery disease
·
By End-User:
Hospitals, Ambulatory surgical centers, Cardiac catheterization laboratories
Among
these, drug-eluting
balloons are gaining strong momentum due to their effectiveness
in preventing restenosis, particularly in high-risk patients.
Regional Insights
·
North America
holds the largest market share, driven by high healthcare expenditure, early
adoption of advanced technologies, and a large population suffering from
lifestyle-related cardiovascular issues.
·
Europe
follows closely, with strong support from healthcare systems and research
initiatives.
·
Asia-Pacific
is expected to witness the fastest growth rate, fueled by an aging
population, increasing awareness of cardiovascular health, and the expansion of
healthcare infrastructure in countries like China and India.
Competitive Landscape
Key
players in the angioplasty balloons market are focused on
R&D, strategic partnerships, and global expansion. Prominent companies
include:
·
Boston Scientific Corporation
·
Medtronic plc
·
Abbott Laboratories
·
Biotronik SE & Co. KG
·
B. Braun Melsungen AG
These
companies are investing heavily in next-gen balloon technologies and expanding
their product portfolios to meet evolving patient needs.
Conclusion
The
global angioplasty
balloons market is witnessing steady growth as healthcare
providers increasingly adopt minimally invasive solutions for cardiovascular
treatment. With rising CVD prevalence, aging populations, and technological
advancements, the market is well-positioned for sustainable expansion through
2030. Healthcare stakeholders, device manufacturers, and investors should align
their strategies to capitalize on this growing demand. Innovation,
accessibility, and patient-centered design will remain key drivers of success
in the evolving angioplasty balloons market.
Top 10 FAQs About the
Angioplasty Balloons Market
1. What
is the size of the angioplasty balloons market in 2022?
The market was valued at US$ 2.71 billion in 2022.
2. What
is the projected market size by 2030?
It is expected to reach US$ 3.60 billion by 2030.
3. What
is the growth rate of the market?
The market is growing at a CAGR of 3.6% from 2022 to 2030.
4. Which
regions dominate the market?
North
America and Europe lead, with Asia-Pacific growing fastest.
5. What
are drug-eluting balloons (DEBs)?
DEBs are balloons coated with medication to prevent vessel re-narrowing.
6. What
are the major applications of angioplasty balloons?
They are mainly used for coronary and peripheral artery disease
treatment.
7. Which
product type is gaining traction?
Drug-eluting
and scoring
balloons are increasingly in demand.
8. Who
are the key market players?
Boston Scientific, Medtronic, Abbott, Biotronik, and B. Braun.
9. Why
is angioplasty preferred over surgery?
It's minimally
invasive, with faster recovery and fewer risks.
10. What
factors are driving market growth?
Rising CVD
cases, technological innovation, and aging
populations.

Comments
Post a Comment